These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 24945909)

  • 1. Spontaneous colitis in Muc2-deficient mice reflects clinical and cellular features of active ulcerative colitis.
    Wenzel UA; Magnusson MK; Rydström A; Jonstrand C; Hengst J; Johansson ME; Velcich A; Öhman L; Strid H; Sjövall H; Hansson GC; Wick MJ
    PLoS One; 2014; 9(6):e100217. PubMed ID: 24945909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD103+ CD11b+ Dendritic Cells Induce Th17 T Cells in Muc2-Deficient Mice with Extensively Spread Colitis.
    Wenzel UA; Jonstrand C; Hansson GC; Wick MJ
    PLoS One; 2015; 10(6):e0130750. PubMed ID: 26121642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
    Johansson ME; Gustafsson JK; Holmén-Larsson J; Jabbar KS; Xia L; Xu H; Ghishan FK; Carvalho FA; Gewirtz AT; Sjövall H; Hansson GC
    Gut; 2014 Feb; 63(2):281-91. PubMed ID: 23426893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochanin a ameliorates DSS-induced ulcerative colitis by improving colonic barrier function and protects against the development of spontaneous colitis in the Muc2 deficient mice.
    Zhang H; Wang X; Zhao L; Zhang K; Cui J; Xu G
    Chem Biol Interact; 2024 May; 395():111014. PubMed ID: 38648921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation.
    Magnusson MK; Brynjólfsson SF; Dige A; Uronen-Hansson H; Börjesson LG; Bengtsson JL; Gudjonsson S; Öhman L; Agnholt J; Sjövall H; Agace WW; Wick MJ
    Mucosal Immunol; 2016 Jan; 9(1):171-82. PubMed ID: 26080709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muc5ac Expression Protects the Colonic Barrier in Experimental Colitis.
    Olli KE; Rapp C; O'Connell L; Collins CB; McNamee EN; Jensen O; Jedlicka P; Allison KC; Goldberg MS; Gerich ME; Frank DN; Ir D; Robertson CE; Evans CM; Aherne CM
    Inflamm Bowel Dis; 2020 Aug; 26(9):1353-1367. PubMed ID: 32385500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC2 and related bacterial factors: Therapeutic targets for ulcerative colitis.
    Yao D; Dai W; Dong M; Dai C; Wu S
    EBioMedicine; 2021 Dec; 74():103751. PubMed ID: 34902790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis.
    van der Post S; Jabbar KS; Birchenough G; Arike L; Akhtar N; Sjovall H; Johansson MEV; Hansson GC
    Gut; 2019 Dec; 68(12):2142-2151. PubMed ID: 30914450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant mucin assembly in mice causes endoplasmic reticulum stress and spontaneous inflammation resembling ulcerative colitis.
    Heazlewood CK; Cook MC; Eri R; Price GR; Tauro SB; Taupin D; Thornton DJ; Png CW; Crockford TL; Cornall RJ; Adams R; Kato M; Nelms KA; Hong NA; Florin TH; Goodnow CC; McGuckin MA
    PLoS Med; 2008 Mar; 5(3):e54. PubMed ID: 18318598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis.
    Matsuno H; Kayama H; Nishimura J; Sekido Y; Osawa H; Barman S; Ogino T; Takahashi H; Haraguchi N; Hata T; Matsuda C; Yamamoto H; Uchino M; Ikeuchi H; Doki Y; Mori M; Takeda K; Mizushima T
    Inflamm Bowel Dis; 2017 Sep; 23(9):1524-1534. PubMed ID: 28700533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic mixture VSL#3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice.
    Kumar M; Kissoon-Singh V; Coria AL; Moreau F; Chadee K
    Am J Physiol Gastrointest Liver Physiol; 2017 Jan; 312(1):G34-G45. PubMed ID: 27856417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
    Wei J; Chen C; Feng J; Zhou S; Feng X; Yang Z; Lu H; Tao H; Li L; Xv H; Xuan J; Wang F
    J Transl Med; 2023 Nov; 21(1):793. PubMed ID: 37940996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance and regulation of the colonic mucus barrier in a mouse model of colitis.
    Petersson J; Schreiber O; Hansson GC; Gendler SJ; Velcich A; Lundberg JO; Roos S; Holm L; Phillipson M
    Am J Physiol Gastrointest Liver Physiol; 2011 Feb; 300(2):G327-33. PubMed ID: 21109593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muc2 Mucin and Nonmucin Microbiota Confer Distinct Innate Host Defense in Disease Susceptibility and Colonic Injury.
    Leon-Coria A; Kumar M; Workentine M; Moreau F; Surette M; Chadee K
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):77-98. PubMed ID: 32659381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Stimulation Using a Gut Microbe-Based Immunotherapy Reduces Disease Pathology and Improves Barrier Function in Ulcerative Colitis.
    Sham HP; Bazett M; Bosiljcic M; Yang H; Luk B; Law HT; Morampudi V; Yu HB; Pankovich J; Sutcliffe S; Bressler B; Marshall JK; Fedorak RN; Chen J; Jones M; Gunn H; Kalyan S; Vallance BA
    Front Immunol; 2018; 9():2211. PubMed ID: 30319652
    [No Abstract]   [Full Text] [Related]  

  • 16. The goblet cell-derived mediator RELM-β drives spontaneous colitis in Muc2-deficient mice by promoting commensal microbial dysbiosis.
    Morampudi V; Dalwadi U; Bhinder G; Sham HP; Gill SK; Chan J; Bergstrom KS; Huang T; Ma C; Jacobson K; Gibson DL; Vallance BA
    Mucosal Immunol; 2016 Sep; 9(5):1218-33. PubMed ID: 26813339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective post-transcriptional processing of MUC2 mucin in ulcerative colitis and in Crohn's disease increases detectability of the MUC2 protein core.
    Hanski C; Born M; Foss HD; Marowski B; Mansmann U; Arastéh K; Bachler B; Papenfuss M; Niedobitek F
    J Pathol; 1999 Jul; 188(3):304-11. PubMed ID: 10419600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative Colitis.
    Alipour M; Zaidi D; Valcheva R; Jovel J; Martínez I; Sergi C; Walter J; Mason AL; Wong GK; Dieleman LA; Carroll MW; Huynh HQ; Wine E
    J Crohns Colitis; 2016 Apr; 10(4):462-71. PubMed ID: 26660940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
    Lennon G; Balfe Á; Bambury N; Lavelle A; Maguire A; Docherty NG; Coffey JC; Winter DC; Sheahan K; O'Connell PR
    Colorectal Dis; 2014 May; 16(5):O161-9. PubMed ID: 24345279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.